Gülçin Kantarcı

ORCID: 0000-0002-5350-9797
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Muscle and Compartmental Disorders
  • Acute Kidney Injury Research
  • Renal Transplantation Outcomes and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Renal function and acid-base balance
  • Restraint-Related Deaths
  • Chronic Kidney Disease and Diabetes
  • Renal and Vascular Pathologies
  • Pancreatitis Pathology and Treatment
  • Renal Diseases and Glomerulopathies
  • Neurological and metabolic disorders
  • Infectious Diseases and Tuberculosis
  • Nutrition and Health in Aging
  • Organ Transplantation Techniques and Outcomes
  • Erythropoietin and Anemia Treatment
  • Polyomavirus and related diseases
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Vasculitis and related conditions
  • Liver Disease and Transplantation
  • Sepsis Diagnosis and Treatment
  • Clinical Nutrition and Gastroenterology
  • Inflammasome and immune disorders
  • Electrolyte and hormonal disorders
  • Parvovirus B19 Infection Studies

Yeditepe University
2008-2021

Marmara University
2000-2016

Pediatric Nephrology of Alabama
2012-2016

Psychiatric Association of Turkey
2012

Yeditepe University Hospital
2008-2009

Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi
2006-2007

Istanbul Eye Hospital
2006

Social Security Children's Hospital
2004

Ghent University Hospital
2002

Üsküdar University
2002

Hyperkalemia is a major cause of mortality in the patients who suffer from crush syndrome aftermath earthquakes. The aim this study to investigate frequency and effects hyperkalemia 639 victims catastrophic Marmara earthquake that struck northwestern Turkey, August 1999.Within first week disaster, questionnaires were sent 35 reference hospitals treated victims. Information on serum potassium which was provided 595 out submitted analysis.In admitted within 3 days disaster (n = 401) 5.4 +/-...

10.5414/cnp59326 article EN Clinical Nephrology 2003-05-01

We aimed to evaluate possible risk factors assocıated wıth acute kidney injury (AKI) after hip fracture surgery in the elderly individuals.Level II diagnostic study, evidence obtained from prospective cohort study 1 center with level 2, and 3 patients.A total of 165 patients (>65 years) femoral neck were enrolled this between 2007 2010. Two dropped for inadequate laboratory follow-up data. Patients failure or renal replacement therapy (RRT) history AKI at admission excluded.Nephrology...

10.1177/2151458512473827 article EN cc-by-nc Geriatric Orthopaedic Surgery & Rehabilitation 2012-12-01

OBJECTIVE: Cardiac and kidney diseases are common, the impact of acute injury (AKI) on patient outcome is well known. We aimed to investigate incidence cardiorenal syndrome (CRS) risk factors outcomes associated with disease. METHODS: conducted a retrospective cohort study comprising 289 patients coronary (ACS) decompensated heart failure (ADHF), examining AKI defined according Acute Kidney Injury Network (AKIN) classification, contributing AKI, in-hospital mortality hospital re-admission....

10.1159/000337714 article EN Cardiorenal Medicine 2012-01-01

<b><i>Background/Aims: </i></b>The aim of the present study was to investigate effect combination aliskiren with paricalcitol on experimental diabetic nephropathy (DN) model in rats. <b><i>Methods: </i></b>Forty male Sprague Dawley rats were divided into 5 groups 8 each, namely control (Group C), diabetes D), A), P), and plus A+P) groups. Aliskiren given by oral-gavage at a dose 50 mg/kg/day once daily for 12 weeks. Paricalcitol...

10.1159/000368471 article EN cc-by-nc Kidney & Blood Pressure Research 2014-01-01

<b><i>Background:</i></b> This study aimed at investigating the possible protective effect of erythropoietin beta on experimental diabetic nephropathy (DN) model in rats. <b><i>Methods:</i></b> Sprague Dawley rats (n = 32) were allocated into 4 equal groups 8 each, control (Group C), diabetes D), E), and treated DN E + D) groups. Streptozocin (65 mg/kg) was used to induce 10-week old Erythropoietin given intraperitoneally a dose 500 IU/kg/3...

10.1159/000444649 article EN ˜The œNephron journals/Nephron journals 2016-01-01

SUMMARY: Background: The management of steroid‐resistant glomerulopathies remains a clinical problem. In this trial, we report observation 43 patients treated with mycophenolate mofetil (MMF) for glomerulopathies. Methods: All underwent renal biopsies, and immunofluorescence light microscopy examinations were conducted in all cases. had been prednisone at dose 1 mg/kg per day least 8 weeks. Of the patients, 16 cyclophosphamide five cyclosporine A before MMF started. primary study outcomes...

10.1111/j.1440-1797.2006.00763.x article EN Nephrology 2007-03-16

Saccharomyces cerevisiae, known as baker's yeast, is also used a probiotic agent to treat gastroenteritis by modulating the endogenous flora and immune system. However, since there have been increasing reports of fungemia due S.cerevisiae its subspecies S.boulardii, it recommended that probiotics should be cautiously in immunosuppressed patients, people with underlying diseases low-birth weight babies. To emphasize this phenomenon, report, case developed patient given treatment for...

10.5578/mb.6970 article EN Mikrobiyoloji Bulteni 2014-04-28

Prolongation of repolarization dispersion (QT interval dispersion) measured from the 12-lead surface ECG has been associated with sudden cardiac death and ventricular tachyarrhythmias in a variety disorders. The aim our study was to assess effects hemodialysis (HD) continuous ambulatory peritoneal dialysis (CAPD) on QT end-stage renal disease patients. 20 chronic HD patients (mean age 57.75 ± 13.79 years) CAPD 50.79 14.94 who had no complaints symptoms arrhythmias as well healthy volunteers...

10.1159/000065038 article EN ˜The œNephron journals/Nephron journals 2002-01-01

<i>Background:</i> Familial Mediterranean fever (FMF) is the major cause of AA amyloidosis in Turkey. M694V mutation MEFV gene was suggested to be associated with severe clinical features and FMF. <i>Methods:</i> In this study, frequencies three FMF-related mutations (M694V, M680I V726A) were investigated FMF patients (AA-FMF, n = 37) without (non-AA-FMF, 35), secondary related non-FMF inflammatory conditions (S-AA, 19) a non-inflammatory control group (n 185) by...

10.1159/000077375 article EN Nephron Clinical Practice 2004-05-03

Background. Familial Mediterranean fever (FMF) is an autosomal recessive disease seen primarily in Sephardic Jews, Turks, and Armenians. The manifests as recurrent attacks of serositis. most important complication FMF the development renal failure due to AA type amyloidosis. There has not been extensive experience with replacement therapy Nevertheless, there may be a concern about possibility higher rates morbidity mortality amyloidotic patients maintained on chronic hemodialysis. Moreover,...

10.1080/08860220601166560 article EN Renal Failure 2007-01-01

Gul Sagun, MD*, Gulcin Kantarci, MD†, Banu Mesci, Sinem Gungor, Funda Turkoglu, Elif Yorulmaz, MD* and Aytekin Oguz, *Department of Internal Medicine, Goztepe Training Research Hospital, Istanbul, Turkey †Department Nephrology, Corresponding Author: MD; Department Medicine; Hospital; Tonozlu sok, Emek apt No: 5 Kat: Daire: 21; Saskinbakkal, Suidiye, Istanbul Turkey; Tel: 0216 566 40 00; Email: gulsagun{at}yahoo.com

10.3121/cmr.2010.892 article EN Clinical Medicine & Research 2010-08-03

Aim We carried out the present study to determine prevalence, associated comorbidities and impact on mortality of chronic kidney disease ( CKD ) in nursing home residents. Methods This was an 8‐year prospective single‐center, longitudinal cohort consisting 612 patients living a from 2005–2013. The glomerular filtration rate GFR estimated prediction equation, C hronic K idney D isease E pidemiology ollaboration based serum creatinine concentration, age, race, sex body size. demographic...

10.1111/ggi.12337 article EN Geriatrics and gerontology international/Geriatrics & gerontology international 2014-09-26
Coming Soon ...